About Us
A breakthrough approach in aesthetics and healing.
At Conexeu, we see a future where tissue regeneration sets the standard for medical care. Building on our core mission—to lead the next evolution in regenerative tissue engineering—we’re delivering scalable, clinically proven, and economically viable regenerative collagen solutions that minimize risks and maximize patient outcomes.
Vision
To usher in a future where CXU™ technology—engineered to mirror the body’s own extracellular matrix—makes self-healing the new standard of care, so every person can regenerate, not just repair by scarring, their skin and tissue.
Mission
Conexeu develops and supplies collagen-based technologies that let doctors and patients regenerate tissue naturally, safely, and effectively.
We serve trauma surgeons, reconstructive surgeons, plastic surgeons, as well as the millions of people seeking alternatives to dermal synthetic fillers or grafts.
By pairing natural, biocompatible and biodegradable ingredients naturally found in our human skin, with user-friendly delivery formats, we can help partners scale first-in-class regenerative treatments worldwide.
We are building a new class of regenerative natural tissue matrices from our patented ground breaking research.
Research Driven Innovation
Built on a decade of R&D into collagen’s biological activity, Conexeu’s proprietary formulations are designed to enable faster and more complete tissue repair.
Our collagen-based scaffold platform powers multiple high-value therapeutic and aesthetic indications, representing a major leap forward in regenerative medicine.
We are ushering in an era where collagen extracellular matrix therapies are accessible to all, reshaping the future of regenerative tissue engineering.
A Transformational Opportunity in Regenerative Medicine
Growing Market Demand.
The global shift toward safer, natural aesthetic and reconstructive solutions continues to expand.
Provisional Science.
Supported by preclinical, peer-reviewed data, Conexeu’s patented collagen-based scaffold approach is being investigated for applications ranging from facial rejuvenation to large-volume body contouring.
Seasoned Leadership.
World-renowned physicians in aesthetics and wound care, tissue-engineering PhDs, former CEOs/CMOs of global aesthetics leaders, and medical device veterans with proven FDA-clearance track records.
“Join Us in Shaping the Future of Regenerative Medicine”
With its innovative collagen based technology, Conexeu bridges the gap between facial fillers, biostimulators and tissue repair. We’re igniting a paradigm shift in how medicine approaches tissue repair. From investors seeking high-growth opportunities to clinicians pursuing safer and more effective therapies—everyone benefits from a future driven by true regeneration.
Be the First to Know When We Hit Our Next Milestone
Join our newsletter to track our innovations and breakthroughs.
"*" indicates required fields